Hypothalamic hamartoma with gelastic seizures in Swedish children and adolescents

Göran Brandberg1, Raili Raininko, Orvar Eeg-Olofsson

  • 1Department of Pediatrics, County Hospital, Falun Sweden.

Insights

Early diagnosis of hypothalamic hamartoma with gelastic seizures (HHGS) is crucial. Neurosurgery offers the most effective treatment for this rare childhood epilepsy syndrome.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Neuroimaging

Background:

  • Hypothalamic hamartoma with gelastic seizures (HHGS) is a rare and often overlooked childhood epilepsy syndrome.
  • Symptoms typically manifest in early childhood, presenting diagnostic challenges.

Purpose of the Study:

  • To investigate the incidence, clinical features, and diagnostic approaches for HHGS in Swedish children and adolescents.
  • To evaluate treatment outcomes for HHGS.

Main Methods:

  • A nationwide survey identified 12 pediatric patients with HHGS.
  • Hospital records were reviewed, and MRI examinations were re-evaluated.
  • EEG, SPECT, and PET scans were performed in select cases.

Main Results:

  • Gelastic seizures often began before six months of age, with other seizure types developing in most patients.
  • Behavioral disorders, mental retardation, and precocious puberty were common comorbidities.
  • MRI revealed hypothalamic tumors in 11 patients; neurosurgery improved gelastic seizures and behavior in three treated individuals.

Conclusions:

  • Early diagnosis of HHGS is vital, with "laughing attacks" being a key indicator.
  • Magnetic Resonance Imaging (MRI) is essential for diagnosis.
  • Neurosurgical intervention for the hypothalamic hamartoma is the primary treatment modality.
Abstract

Related Concept Videos

Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...